Exclusive license for use of gabapentin in the above indications in EU, Canada, Australia, New Zealand. US Phase 3 trials of MR-gabapentin for menopause by PharmaNova’s US licensee (Depomed, Inc) will complete in 3Q 2009; Co-promotion in US is possible. More
A validated high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry method for measuring the absolute quantities of fifteen endogenous estrogens and their metabolites in human urine. More
An improved method for producing human growth hormone (hGH) in vitro or in vivo. This invention can be applied to a non-invasive method of gene therapy to achieve sustained delivery of this therapeutic protein. More
Clinical identification of a new disease termed "isolated micronodular adrenocortical disease" (iMAD), as well as the role of PDE11A gene in this disease More
This technology involves a validated, enzyme linked immunosorbent assay (ELISA) with a chemiluminescence readout, using commercially available antibodies to quantitate total TopoI from cell and tumor extracts. More
All rights reserved. Terms and Conditions | Contact us
